NCT03753477 - Clinical Trial to Investigate the Efficacy and Safety of DWJ1351 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 22, 2017

Primary Completion Date

January 26, 2018

Study Completion Date

February 1, 2018

Conditions

Healthy

Interventions

DRUG

DWJ1351(FDC Amlodipine/Olmesartan/Rosuvastatin)

DWJ1351(FDC Amlodipine/Olmesartan/Rosuvastatin) X 1 tablet followed by Sevikar(Amlodipine/Olmesartan) X 1 tablet and Crestor(Rosuvastatin) X 1 tablet (after washout period)

DRUG

Sevikar and Crestor

Sevikar(Amlodipine/Olmesartan) X 1 tablet and Crestor(Rosuvastatin) X 1 tablet followed by FDC Amlodipine/Olmesartan/Rosuvastatin X 1 tablet (after washout period)

Trial Locations (1)

Unknown

Busan Paik Hospital, Busan